16-week Open Randomized Comparative Effectiveness Trial of Lamotrigine vs. Fluoxetine for Bipolar Depression: Pharmacogenomic and Biomarker Predictors of Response
Phase of Trial: Phase IV
Latest Information Update: 29 May 2018
At a glance
- Drugs Fluoxetine (Primary) ; Lamotrigine (Primary)
- Indications Bipolar depression
- Focus Therapeutic Use
- Acronyms FLAME
- 23 May 2018 Status changed from recruiting to completed.
- 15 Apr 2016 Status changed from active, no longer recruiting to recruiting.
- 15 Dec 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.